VAL-181388
Phase 1Completed 1 views this week 0 watching
0
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Chikungunya Virus
Conditions
Chikungunya Virus
Trial Timeline
Jul 19, 2017 → Mar 19, 2019
NCT ID
NCT03325075About VAL-181388
VAL-181388 is a phase 1 stage product being developed by Moderna for Chikungunya Virus. The current trial status is completed. This product is registered under clinical trial identifier NCT03325075. Target conditions include Chikungunya Virus.
What happened to similar drugs?
0 of 11 similar drugs in Chikungunya Virus were approved
Approved (0) Terminated (2) Active (9)
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03325075 | Phase 1 | Completed |
Competing Products
20 competing products in Chikungunya Virus